Phase 1 study of interleukin-12 in combination with rituximab inpatients with B-cell non-Hodgkin's lymphoma

Stephen M. Ansell, Thomas E. Witzig, Paul J. Kurtin, Jeff A. Sloan, Diane F. Jelinek, Kyle G. Howell, Svetomir N. Markovic, Thomas M. Habermann, George G. Klee, Pamela J. Atherton, Charles Erlichman

Research output: Contribution to journalArticlepeer-review

128 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study of interleukin-12 in combination with rituximab inpatients with B-cell non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds